SAN FRANCISCO – December 10, 2014 – iRhythm Technologies, Inc, a leading digital health care solutions company focusing on the advancement of cardiac care, today announced that it has earned The Joint Commission's Gold Seal of Approval® for Ambulatory Health Care Accreditation by demonstrating continuous compliance with its nationally-recognized standards. The Gold Seal of Approval® is a symbol of quality that reflects an organization's commitment to providing safe and effective patient care.
iRhythm Technologies, Inc. underwent a rigorous, initial on-site survey. During the survey, a team of Joint Commission expert surveyors evaluated compliance with ambulatory care standards related to a variety of areas, including coordination of care, and patient education. The Joint Commission's ambulatory health care standards are developed in consultation with health care experts and providers, measurement experts, and patients. The standards are informed by scientific literature and expert consensus to help organizations measure, assess and improve performance.
"iRhythm Technologies, Inc. is delighted to receive accreditation from The Joint Commission," added Judy Lenane, RN, MHA, executive vice president and chief clinical officer of iRhythm Technologies, Inc. "With our comprehensive continuous heart monitoring data and deep understanding of cardiology, we are providing clinicians with meaningful information to accurately diagnose and better manage patients with cardiac arrhythmias. The accreditation validates our efforts, which are deeply rooted in data analytics, to provide significant, personalized and high-quality data that informs patient care."
iRhythm Technologies, Inc. develops and commercializes the ZIO® Service, which includes the ZIO® XT Patch, proprietary algorithms and the ZIO Report that is revolutionizing how cardiac arrhythmias, including atrial fibrillation, are diagnosed. The ZIO Service provides the only long-term continuous monitoring approach that is proven to help clinicians rule in and rule out arrhythmias earlier in the diagnostic pathway and to change patient management. Since becoming available commercially in 2011, the ZIO Service has been used with more than 250,000 patients at over 1,000 institutions across the U.S. Additionally, the ZIO Service is covered for Medicare patients and by leading private payers nationwide, representing approximately 200 million covered lives.
Additionally, iRhythm Technologies, Inc. is certified by the International Organization for Standardization (ISO) and the Canadian Medical Devices Conformity Assessment System (CMDCAS), which both ensure the quality, safety and efficiency of medical devices and related services provided.
Established in 1975, The Joint Commission's Ambulatory Health Care Accreditation program encourages high quality patient care in all types of freestanding ambulatory care facilities. An estimated 2,100 organizations currently maintain Ambulatory Health Care Accreditation, awarded for a three-year period.
###
About The Joint Commission
Founded in 1951, The Joint Commission seeks to continuously improve health care for the public, in collaboration with other stakeholders, by evaluating health care organizations and inspiring them to excel in providing safe and effective care of the highest quality and value. The Joint Commission accredits and certifies more than 20,500 health care organizations and programs in the United States, including hospitals and health care organizations that provide ambulatory and office-based surgery, behavioral health, home care, laboratory and nursing home services. An independent, not-for-profit organization, The Joint Commission is the nation's oldest and largest standards-setting and accrediting body in health care. The Joint Commission has two nonprofit affiliate organizations: The Joint Commission Center for Transforming Healthcare aims to solve health care's most critical safety and quality problems and Joint Commission Resources (JCR) provides consulting services, educational services and publications. Joint Commission International, a division of JCR, accredits and certifies international health care organizations. Learn more about The Joint Commission at www.jointcommission.org.
About iRhythm Technologies, Inc.
iRhythm is a privately held digital healthcare company that aspires to be the world leader in cardiac arrhythmia information. iRhythm develops and commercializes FDA-cleared solutions that integrate consumer-friendly biosensor technology, vast patient data, powerful analytics and medical expertise. Its flagship solution, the ZIO Service, offers a proven approach to long-term continuous monitoring that enables diagnosis earlier in the clinical pathway to improve patient outcomes and reduce healthcare costs. For more information, please visit www.irhythmtech.com.
Media Contact
Amanda Breeding
415-229-7649
###